Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Physiol Behav ; 278: 114508, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38460779

ABSTRACT

BACKGROUND: Neurodegenerative disorders are associated with chronic neuroinflammation, which contributes to their pathogenesis and progression. Resveratrol (RSV) is a polyphenolic compound with strong antioxidant and anti-inflammatory properties. In the present study, we investigated whether RSV could protect against cognitive impairment and inflammatory response in a mouse model of chronic neuroinflammation induced by lipopolysaccharide (LPS). METHOD: Mice received oral RSV (30 mg/kg) or vehicle for two weeks, and injected with LPS (0.75 mg/kg) or saline daily for the last seven days. After two weeks, mice were subjected to behavioral assessments using the Morris water maze and Y-maze. Moreover, mRNA expression of several inflammatory markers, neuronal loss, and glial density were evaluated in the hippocampus of treated mice. RESULTS: Our findings showed that RSV treatment effectively improved spatial and working memory impairments induced by LPS. In addition, RSV significantly reduced hippocampal glial densities and neuronal loss in LPS-injected mice. Moreover, RSV treatment suppressed LPS-induced upregulation of NF-κB, IL-6, IL-1ß, and GFAP in the hippocampus of treated mice. CONCLUSION: Taken together, our results highlight the detrimental effect of systemic inflammation on the hippocampus and the potential of natural products with anti-inflammatory effects to counteract this impact.


Subject(s)
Cognitive Dysfunction , Lipopolysaccharides , Mice , Animals , Resveratrol/therapeutic use , Lipopolysaccharides/toxicity , Neuroinflammatory Diseases , Microglia/metabolism , Cognitive Dysfunction/chemically induced , Cognitive Dysfunction/drug therapy , Cognitive Dysfunction/metabolism , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Inflammation/chemically induced , Inflammation/drug therapy , Inflammation/metabolism , Disease Models, Animal , NF-kappa B/metabolism , Hippocampus/metabolism , Maze Learning
2.
Andrologia ; 54(8): e14470, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35679508

ABSTRACT

NOX5 is introduced as a new therapeutic target for infertility treatment. This study aimed to compare the basal and stimulated reactive oxygen species (ROS) production and sperm function in human teratozoospermic (n = 15) and normozoospermic (n = 17) semen samples following calcium overload and NOX5 activation. Washed spermatozoa incubated for 1 h under five various conditions: control group, adding a calcium ionophore A23187, phorbol myristate acetate (PMA), A23187 + PMA, and diphenylene iodonium (DPI) + A23187 + PMA. ROS generation was measured immediately after treatment for 30 min. Motility, viability, acrosome reaction, and apoptosis were evaluated after 1-h incubation. ROS production significantly increased when A23187 or PMA was added to the sperm medium. DPI had suppressive effects on ROS generation. Progressive and total motility significantly decreased following calcium elevation and NOX5 activation, which was somewhat returned by DPI. Necrotic and live cells in teratozoospermia was, respectively, higher and lower than normozoospermia samples. Incubation with A23187 significantly increased the percentage of early and late apoptosis. Teratozoosperm are more vulnerable than normal spermatozoa, and produce more basal and stimulated ROS. It seems that calcium overload induces apoptosis in spermatozoa and loss of viability through MPT pore opening and increased intracellular ROS.


Subject(s)
Calcium , NADPH Oxidase 5 , Reactive Oxygen Species , Spermatozoa , Calcimycin/pharmacology , Calcium/metabolism , Humans , Male , NADPH Oxidase 5/genetics , NADPH Oxidase 5/metabolism , Reactive Oxygen Species/metabolism , Semen/drug effects , Semen/metabolism , Sperm Motility/drug effects , Sperm Motility/genetics , Sperm Motility/physiology , Spermatozoa/drug effects , Spermatozoa/metabolism
3.
Parasitol Res ; 121(7): 1853-1865, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35552534

ABSTRACT

Toxoplasma gondii is a pathogenic protozoan parasite belonging to the apicomplexan phylum that infects the nucleated cells of warm-blooded hosts leading to an infectious disease known as toxoplasmosis. Apicomplexan parasites such as T. gondii can display different mechanisms to control or manipulate host cells signaling at different levels altering the host subcellular genome and proteome. Indeed, Toxoplasma is able to modulate host cell responses (especially immune responses) during infection to its advantage through both structural and functional changes in the proteome of different infected cells. Consequently, parasites can transform the invaded cells into a suitable environment for its own replication and the induction of infection. Proteomics as an applicable tool can identify such critical proteins involved in pathogen (Toxoplasma)-host cell interactions and consequently clarify the cellular mechanisms that facilitate the entry of pathogens into host cells, and their replication and transmission, as well as the central mechanisms of host defense against pathogens. Accordingly, the current paper reviews several proteins (identified using proteomic approaches) differentially expressed in the proteome of Toxoplasma-infected host cells (macrophages and human foreskin fibroblasts) and tissues (brain and liver) and highlights their plausible functions in the cellular biology of the infected cells. The identification of such modulated proteins and their related cell impact (cell responses/signaling) can provide further information regarding parasite pathogenesis and biology that might lead to a better understanding of therapeutic strategies and novel drug targets.


Subject(s)
Toxoplasma , Toxoplasmosis , Host-Parasite Interactions , Humans , Proteome/metabolism , Proteomics , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Toxoplasma/genetics , Toxoplasmosis/parasitology
4.
Acta Trop ; 231: 106431, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35367408

ABSTRACT

Micro RNAs (miRNAs), as regulators of gene expression at the post-transcriptional level, can respond to/or interact with cell signaling and affect the pathogenesis of different diseases/infections. The interaction/crosstalk of miRNAs with various cellular signaling networks including mTOR (as a master regulator of signaling relevant to different cellular mechanisms) might lead to the initiation, progression or restriction of certain disease processes. There are numerous studies that have identified the crosstalk between regulatory miRNA expression and the mTOR pathway (or mTOR signaling regulated by miRNAs) in different diseases which has a dual function in pathogenesis. However, the corresponding information in parasitic infections remains scarce. miRNAs have been suggested as specific targets for therapeutic strategies in several disorders such as parasitic infections. Thus, the targeting of miRNAs (as the modulators/regulators of mTOR) by small molecules and RNA-based therapeutics and consequently managing and modulating mTOR signaling and the downstream/related cell signaling/pathways might shed some light on the design of new therapeutic strategies against parasitic diseases, including Leishmaniasis. Accordingly, the present study attempts to highlight the importance of the crosstalk between regulatory miRNAs and mTOR signaling, and to review the relevant insights into parasitic infections by focusing specifically on Leishmania.


Subject(s)
Leishmaniasis , MicroRNAs , Parasitic Diseases , Humans , Immunity , Leishmaniasis/genetics , Leishmaniasis/parasitology , MicroRNAs/genetics , Signal Transduction , TOR Serine-Threonine Kinases/genetics
5.
Parasitol Res ; 121(1): 49-62, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34993638

ABSTRACT

The current drug treatments against protozoan parasitic diseases including Chagas, malaria, leishmaniasis, and toxoplasmosis represent good examples of drug resistance mechanisms and have shown diverse side effects. Therefore, the identification of novel therapeutic strategies and drug compounds against such life-threatening diseases is urgent. According to the successful usage of selenium (Se) compounds-based therapy against some diseases, this therapeutic strategy has been recently further underlined against these parasitic diseases by targeting different parasite´s essential pathways. On the other hand, due to the important functions played by parasite selenoproteins in their biology (such as modulating the host immune response), they can be also considered as a novel therapeutic strategy by designing specific inhibitors against these important proteins. In addition, the immunomodulatory potentiality of these compounds to trigger T helper type 1 (Th1) cells and cytokine-mediated immune response for the substantial induction of proinflammatory cytokines, thus, Se, selenoproteins, and parasite selenoproteins could be further investigated to find possible vaccine antigens. Herein, we collect and present the results of some studies regarding Se-based therapy against protozoan parasitic diseases and highlight relevant information and some viewpoints that might be insightful to advance toward more effective studies in the future.


Subject(s)
Immunity, Cellular , Protozoan Infections/drug therapy , Selenium , Selenoproteins , Animals , Humans , Selenium/pharmacology
6.
Parasitology ; 148(12): 1434-1446, 2021 10.
Article in English | MEDLINE | ID: mdl-34218829

ABSTRACT

Leishmania parasites, the causative agents of leishmaniasis, are protozoan parasites with the ability to modify the signalling pathway and cell responses of their infected host cells. These parasite strategies alter the host cell environment and conditions favouring their replication, survival and pathogenesis. Since microRNAs (miRNAs) are able to post-transcriptionally regulate gene expression processes, these biomolecules can exert critical roles in controlling Leishmania-host cell interplay. Therefore, the identification of relevant miRNAs differentially expressed in Leishmania parasites as well as in infected cells, which affect the host fitness, could be critical to understand the infection biology, pathogenicity and immune response against these parasites. Accordingly, the current review aims to address the differentially expressed miRNAs in both, the parasite and infected host cells and how these biomolecules change cell signalling and host immune responses during infection. A deep understanding of these processes could provide novel guidelines and therapeutic strategies for managing and treating leishmaniasis.


Subject(s)
Leishmania , Leishmaniasis , MicroRNAs , Parasites , Animals , Leishmaniasis/parasitology , MicroRNAs/genetics , MicroRNAs/metabolism , Signal Transduction
7.
J Proteomics ; 245: 104279, 2021 08 15.
Article in English | MEDLINE | ID: mdl-34089893

ABSTRACT

There are important challenges when investigating individual post-translational modifications (PTMs) or protein interaction network and delineating if PTMs or their changes and cross-talks are involved during infection, disease initiation or as a result of disease progression. Proteomics and in silico approaches now offer the possibility to complement each other to further understand the regulatory involvement of these modifications in parasites and infection biology. Accordingly, the current review highlights key expressed or altered proteins and PTMs are invisible switches that turn on and off the function of most of the proteins. PTMs include phosphorylation, glycosylation, ubiquitylation, palmitoylation, myristoylation, prenylation, acetylation, methylation, and epigenetic PTMs in P. falciparum which have been recently identified. But also other low-abundant or overlooked PTMs that might be important for the parasite's survival, infectivity, antigenicity, immunomodulation and pathogenesis. We here emphasize the PTMs as regulatory pathways playing major roles in the biology, pathogenicity, metabolic pathways, survival, host-parasite interactions and the life cycle of P. falciparum. Further validations and functional characterizations of such proteins might confirm the discovery of therapeutic targets and might most likely provide valuable data for the treatment of P. falciparum, the main cause of severe malaria in human.


Subject(s)
Malaria, Falciparum , Plasmodium falciparum/metabolism , Animals , Humans , Protein Processing, Post-Translational , Proteomics , Protozoan Proteins/metabolism
8.
Future Microbiol ; 16: 607-613, 2021 05.
Article in English | MEDLINE | ID: mdl-33998267

ABSTRACT

Apolipoprotein A-I (apo A-I) represents the main component of the Trypanosome lytic factor (TLF) which contributes to the host innate immunity against Trypanosoma and Leishmania. These parasites use complex and multiple strategies such as molecular mimicry to evade or subvert the host immune system. Previous studies have highlighted the adaptation mechanisms of TLF-resistant Trypanosoma species. These data might support the hypothesis that Leishmania parasites (amastigote forms in macrophages) might express apo A-I to bypass and escape from TLF action as a component of the host innate immune responses. The anti-inflammatory property of apo A-I is another mechanism that supports our idea that apo A-I may play a role in Leishmania parasites allowing them to bypass the host innate immune system.


Subject(s)
Apolipoprotein A-I/immunology , Leishmania/immunology , Leishmaniasis/immunology , Protozoan Proteins/immunology , Humans , Immune Evasion , Immunity, Innate , Lipoproteins, HDL/immunology , Macrophages/immunology , Macrophages/parasitology , Molecular Mimicry
9.
J Ethnopharmacol ; 269: 113702, 2021 Apr 06.
Article in English | MEDLINE | ID: mdl-33340598

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Oxidative stress is one of the underlying causes of male infertility. Medicinal plants have many benefits for infertility treatment in men. AIM OF THE STUDY: In the present study, we evaluated in vitro effects of Capparis spinosa leaf extract on human sperm function, DNA fragmentation, and oxidative stress. MATERIALS AND METHODS: We conducted this study on the hydroalcoholic extract of C. spinosa. Polyphenol compounds and antioxidant effects of the leaf and fruit extract were determined by HPLC and DPPH method, respectively. Flavones and flavonols, total flavonoid, total phenolic content, tannin, and the total carbohydrate content were determined calorimetrically. Semen samples from 50 healthy men (20-45 years) were divided into control and experimental (15, 30, and 45 ppm of C. spinosa leaf extract) groups. Motility, viability, lipid peroxidation, and DNA fragmentation were evaluated 24 h after incubation. RESULTS: The antioxidant effect of leaf extract was six times greater than fruit. Progressive and total motility of caper-treated groups (30 and 45 ppm) were crucially higher than the control group. Viability in all treatments was significantly higher than the control group. There was no significant difference in lipid peroxidation. DNA fragmentation in the caper-treated group (45 ppm) was significantly lower than the control group. CONCLUSIONS: Our results suggest the potential positive in vitro effect of C. spinosa leaf extract on human sperm function. The use of C. spinosa leaf extract or its active metabolites in the sperm culture medium may be beneficial for maintaining motility, vitality, and sperm DNA. Since these effects were observed at very low concentrations of caper, other non-antioxidant mechanisms must be considered.


Subject(s)
Antioxidants/pharmacology , Capparis/chemistry , DNA Fragmentation/drug effects , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Spermatozoa/drug effects , Adult , Antioxidants/chemistry , Antioxidants/isolation & purification , Cell Survival/drug effects , Ethnopharmacology , Fruit/chemistry , Humans , Male , Malondialdehyde/metabolism , Middle Aged , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Leaves/chemistry , Plants, Medicinal/chemistry , Polyphenols/chemistry , Polyphenols/isolation & purification , Polyphenols/pharmacology , Semen/chemistry , Sperm Motility/drug effects , Spermatozoa/cytology , Young Adult
10.
J Reprod Infertil ; 19(3): 133-139, 2018.
Article in English | MEDLINE | ID: mdl-30167393

ABSTRACT

BACKGROUND: Intracellular calcium and proton concentrations are important factors for activating human sperm. Calcium ion (Ca2+) enters sperm through voltage-dependent calcium channel of sperm (CatSper). Proton was extruded from sperm through voltage-gated proton channel (Hv1). In the present study, the selective inhibitors of the CatSper and Hv1 channels, NNC 55-0396 (NNC) and zinc ion, respectively, were used to investigate functions of these channels. METHODS: Normal semen samples (n=24) were washed and diluted to 20×106sperm/ml. The diluted sample was divided into 8 groups, containing Ham's F-10 (the control group), 2 µM NNC, 1 mM ZnCl2 and NNC+Zn. The other 4 groups were the same as above, except that they contained 1 µM progesterone. The computer assisted analysis was done by VT-Sperm 3.1 to determine the percentage of motile sperm and sperm velocity. Acrosomal status was monitored by FITC-PSA and viability assessed by Eosin-Y staining. Statistical comparisons were made using ANOVA followed by Tukey post hoc test. The p<0.05 was considered significant. RESULTS: The percentage of viable and motile sperm, curvilinear velocity and other parameters of motility was reduced in all groups containing NNC, zinc and NNC+ zinc. Progesterone-induced acrosome reaction was abolished by each of these inhibitors. The combination effect of NNC plus zinc on motility and progesterone-induced acrosome reaction was not stronger than NNC by itself. CONCLUSION: CatSper and Hv1 channels play a critical role in human sperm function and viability. It seems that a functional relationship exists between CatSper and Hv1 channels.

11.
Oncol Lett ; 15(6): 10084-10090, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29928378

ABSTRACT

5-Fluorouracil (5-FU)-based chemotherapy improves the overall survival rates of patients with colorectal cancer (CRC). However, only a small proportion of patients respond to 5-FU when used as a single agent. The aim of the present study was to investigate whether the anticancer property of 5-FU is potentiated by combination treatment with acriflavine (ACF) in CRC cells. Additionally, the potential underlying molecular mechanisms of the cytotoxic effect of ACF were determined. The cytotoxic effects of ACF, 5-FU and irinotecan on different CRC cell lines with different p53 status were investigated using an MTT assay. SW480 cells that express a mutated form of p53 and two other CRC cell lines were used, HCT116 and LS174T, with wild-type p53. To determine the effect of ACF on the sensitivity of cells to 5-FU, cells were co-treated with the 30% maximal inhibitory concentration (IC30) of ACF and various concentrations of 5-FU, or pretreated with the IC30 of ACF and various concentrations of 5-FU. To assess the mechanism of action of ACF, cells were treated with IC30 values of the compound and then the reverse transcription-quantitative polymerase chain reaction was used to evaluate mRNA levels of hypoxia-inducible factor-1α (HIF-1α) and topoisomerase 2. Results indicate that pretreatment with ACF markedly sensitized CRC cells to the cytotoxic effects of 5-FU, whereas simultaneous treatment with ACF and 5-FU were not able to alter the resistance of CRC cells to 5-FU. In comparison with irinotecan, ACF was a more potent agent for enhancing the antitumor activity of 5-FU. ACF did not alter the mRNA levels of either HIF-1α or topoisomerase 2. The results of the present study reveal for the first time that pretreatment of CRC cells with ACF markedly increases the cytotoxic effects of 5-FU, regardless of the p53 status of cells.

12.
Toxicology ; 244(1): 42-8, 2008 Feb 03.
Article in English | MEDLINE | ID: mdl-18055092

ABSTRACT

A synaptosomal model was used to evaluate in vivo effects of paraoxon on the uptake of [(3)H]GABA in rat cerebral cortex and hippocampus. Male Wistar rats were given a single intraperitoneal injection of one of three doses of paraoxon (0.1, 0.3, or 0.7 mg/kg) and acetylcholinesterase (AChE) activity in the plasma, cerebral cortex, and hippocampus was measured at 30 min, 4h, and 18 h after exposure. [(3)H]GABA uptake in synaptosomes was also studied in another series of animals. Paraoxon administration (0.3 and 0.7 mg/kg) caused significant inhibition of AChE activity in the plasma and both brain areas at all time points. 0.1 mg/kg paraoxon significantly inhibited AChE activity but only in the plasma for 4h, the activity was completely recovered at 18 h. GABA uptake was significantly (p<0.001) reduced in both cerebral cortex (18-32%) and hippocampal (16-23%) synaptosomes at all three time points after administering 0.7 mg/kg of paraoxon, a dose that seems to be sufficient to induce seizure activity. L-DABA, an inhibitor of neuronal GABA transporter, allowed us to conclude that the uptake was mediated primarily by neuronal GABA transporter GAT-1. In conclusion, present data suggests that GABA uptake by synaptosomes decreases probably secondary to paraoxon-induced seizure activity.


Subject(s)
Brain/drug effects , Paraoxon/toxicity , Synaptosomes/drug effects , gamma-Aminobutyric Acid/metabolism , Acetylcholinesterase/blood , Animals , Brain/metabolism , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cholinesterase Inhibitors/toxicity , Diarrhea/chemically induced , Dose-Response Relationship, Drug , Fasciculation/chemically induced , GABA Plasma Membrane Transport Proteins/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Male , Nipecotic Acids/pharmacology , Rats , Rats, Wistar , Salivation/drug effects , Synaptosomes/metabolism , Tears/metabolism , Time Factors , Tremor/chemically induced , Tritium , Urination/drug effects , beta-Alanine/pharmacology , gamma-Aminobutyric Acid/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...